09.11.2014 Views

atrial fibrillation and stroke prevention - Continuing Medical ...

atrial fibrillation and stroke prevention - Continuing Medical ...

atrial fibrillation and stroke prevention - Continuing Medical ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Essentials in Primary Care Conference<br />

Wednesday, July 31, 2013<br />

Apixaban Dosing in A Fib<br />

• 5 mg twice daily<br />

• 2.5 mg twice daily for either:<br />

-Age > 80 yrs of age<br />

-Body weight 60 Kg or less<br />

-Creatinine > 1.5 mg/dl<br />

-Dual inhibitors of cytochrome P450 3A4 <strong>and</strong><br />

p-glycoprotein such as ketoconazole <strong>and</strong><br />

clarithromycin<br />

Warfarin Comparison Trials in Atrial Fib<br />

TRIAL RE-LY ROCKET-AF ARISTOTLE<br />

n =18,113 (3 arms) n=14,264 n=18,201<br />

Drug (Br<strong>and</strong> name) Dabigatran (Pradaxa) Rivaroxaban (Xarelto) Apixiban (Eliquis)<br />

150 mg twice a day 20 mg once daily with 5 mg twice a day<br />

evening meal<br />

Trial design, r<strong>and</strong>omized Open label Double blind, double dummy Double blind, double dummy<br />

Mean Age (yrs) 72 73 70<br />

Male ratio 63.6% 60.1% 65.3%<br />

Previous CVA 20% 55% 19%<br />

CHADS score mean 2.1 3.5 2.1<br />

% 0-1 32% 0% 34%<br />

% >3 33% 87% 30%<br />

TTR (%) median/mean ? / 64% 57.8% / 55% 66.0% / 62.2%<br />

Efficacy % vs warfarin 1.71 vs. 1.11 p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!